Pharma & Healthcare
Global Omega-3 Fatty Acid Drugs Market Research Report 2026
- Feb 24, 26
- ID: 717562
- Pages: 129
- Figures: 136
- Views: 3
This report delivers a comprehensive overview of the global Omega-3 Fatty Acid Drugs market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Omega-3 Fatty Acid Drugs. The Omega-3 Fatty Acid Drugs market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Omega-3 Fatty Acid Drugs market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Omega-3 Fatty Acid Drugs manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Woodward Pharma
Amarin Pharmaceuticals
Apotex
Hikma
Dr. Reddy's Laboratories
Teva
Ascent Pharmaceuticals
Zydus
Strides Pharma
PuraCap Pharmaceuticals
Sun Pharma
Mankind Pharma
Amneal Pharmaceuticals
GLW Pharma
Sichuan Gowell Pharmaceutical
Qilu Pharmaceutical
Chengdu Suncadia Medicine
Jiangsu Wangao Pharmaceutical
Humanwell Puracap Pharmaceuticals
Segment by Type
EPA
EPA and DHA
by Application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Omega-3 Fatty Acid Drugs manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Omega-3 Fatty Acid Drugs sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
The report segments the global Omega-3 Fatty Acid Drugs market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Omega-3 Fatty Acid Drugs manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Woodward Pharma
Amarin Pharmaceuticals
Apotex
Hikma
Dr. Reddy's Laboratories
Teva
Ascent Pharmaceuticals
Zydus
Strides Pharma
PuraCap Pharmaceuticals
Sun Pharma
Mankind Pharma
Amneal Pharmaceuticals
GLW Pharma
Sichuan Gowell Pharmaceutical
Qilu Pharmaceutical
Chengdu Suncadia Medicine
Jiangsu Wangao Pharmaceutical
Humanwell Puracap Pharmaceuticals
Segment by Type
EPA
EPA and DHA
by Application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Omega-3 Fatty Acid Drugs manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Omega-3 Fatty Acid Drugs sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
1 Omega-3 Fatty Acid Drugs Market Overview
1.1 Product Definition
1.2 Omega-3 Fatty Acid Drugs by Type
1.2.1 Global Omega-3 Fatty Acid Drugs Market Value by Type: 2025 vs 2032
1.2.2 EPA
1.2.3 EPA and DHA
1.3 Omega-3 Fatty Acid Drugs by Application
1.3.1 Global Omega-3 Fatty Acid Drugs Market Value by Application: 2025 vs 2032
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 Global Omega-3 Fatty Acid Drugs Market Size Estimates and Forecasts
1.4.1 Global Omega-3 Fatty Acid Drugs Revenue 2021–2032
1.4.2 Global Omega-3 Fatty Acid Drugs Sales 2021–2032
1.4.3 Global Omega-3 Fatty Acid Drugs Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Omega-3 Fatty Acid Drugs Market Competition by Manufacturers
2.1 Global Omega-3 Fatty Acid Drugs Sales Market Share by Manufacturers (2021–2026)
2.2 Global Omega-3 Fatty Acid Drugs Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Omega-3 Fatty Acid Drugs Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Omega-3 Fatty Acid Drugs, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Omega-3 Fatty Acid Drugs, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Omega-3 Fatty Acid Drugs, Product Types and Applications
2.7 Global Key Manufacturers of Omega-3 Fatty Acid Drugs, Date of Entry into the Industry
2.8 Global Omega-3 Fatty Acid Drugs Market Competitive Situation and Trends
2.8.1 Global Omega-3 Fatty Acid Drugs Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Omega-3 Fatty Acid Drugs Players Market Share by Revenue
2.8.3 Global Omega-3 Fatty Acid Drugs Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Omega-3 Fatty Acid Drugs Market Scenario by Region
3.1 Global Omega-3 Fatty Acid Drugs Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Omega-3 Fatty Acid Drugs Sales by Region: 2021–2032
3.2.1 Global Omega-3 Fatty Acid Drugs Sales by Region: 2021–2026
3.2.2 Global Omega-3 Fatty Acid Drugs Sales by Region: 2027–2032
3.3 Global Omega-3 Fatty Acid Drugs Revenue by Region: 2021–2032
3.3.1 Global Omega-3 Fatty Acid Drugs Revenue by Region: 2021–2026
3.3.2 Global Omega-3 Fatty Acid Drugs Revenue by Region: 2027–2032
3.4 North America Omega-3 Fatty Acid Drugs Market Facts & Figures by Country
3.4.1 North America Omega-3 Fatty Acid Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Omega-3 Fatty Acid Drugs Sales by Country (2021–2032)
3.4.3 North America Omega-3 Fatty Acid Drugs Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Omega-3 Fatty Acid Drugs Market Facts & Figures by Country
3.5.1 Europe Omega-3 Fatty Acid Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Omega-3 Fatty Acid Drugs Sales by Country (2021–2032)
3.5.3 Europe Omega-3 Fatty Acid Drugs Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Omega-3 Fatty Acid Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Omega-3 Fatty Acid Drugs Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Omega-3 Fatty Acid Drugs Sales by Region (2021–2032)
3.6.3 Asia Pacific Omega-3 Fatty Acid Drugs Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Omega-3 Fatty Acid Drugs Market Facts & Figures by Country
3.7.1 Latin America Omega-3 Fatty Acid Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Omega-3 Fatty Acid Drugs Sales by Country (2021–2032)
3.7.3 Latin America Omega-3 Fatty Acid Drugs Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Omega-3 Fatty Acid Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Omega-3 Fatty Acid Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Omega-3 Fatty Acid Drugs Sales by Country (2021–2032)
3.8.3 Middle East and Africa Omega-3 Fatty Acid Drugs Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Omega-3 Fatty Acid Drugs Sales by Type (2021–2032)
4.1.1 Global Omega-3 Fatty Acid Drugs Sales by Type (2021–2026)
4.1.2 Global Omega-3 Fatty Acid Drugs Sales by Type (2027–2032)
4.1.3 Global Omega-3 Fatty Acid Drugs Sales Market Share by Type (2021–2032)
4.2 Global Omega-3 Fatty Acid Drugs Revenue by Type (2021–2032)
4.2.1 Global Omega-3 Fatty Acid Drugs Revenue by Type (2021–2026)
4.2.2 Global Omega-3 Fatty Acid Drugs Revenue by Type (2027–2032)
4.2.3 Global Omega-3 Fatty Acid Drugs Revenue Market Share by Type (2021–2032)
4.3 Global Omega-3 Fatty Acid Drugs Price by Type (2021–2032)
5 Segment by Application
5.1 Global Omega-3 Fatty Acid Drugs Sales by Application (2021–2032)
5.1.1 Global Omega-3 Fatty Acid Drugs Sales by Application (2021–2026)
5.1.2 Global Omega-3 Fatty Acid Drugs Sales by Application (2027–2032)
5.1.3 Global Omega-3 Fatty Acid Drugs Sales Market Share by Application (2021–2032)
5.2 Global Omega-3 Fatty Acid Drugs Revenue by Application (2021–2032)
5.2.1 Global Omega-3 Fatty Acid Drugs Revenue by Application (2021–2026)
5.2.2 Global Omega-3 Fatty Acid Drugs Revenue by Application (2027–2032)
5.2.3 Global Omega-3 Fatty Acid Drugs Revenue Market Share by Application (2021–2032)
5.3 Global Omega-3 Fatty Acid Drugs Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Woodward Pharma
6.1.1 Woodward Pharma Company Information
6.1.2 Woodward Pharma Description and Business Overview
6.1.3 Woodward Pharma Omega-3 Fatty Acid Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Woodward Pharma Omega-3 Fatty Acid Drugs Product Portfolio
6.1.5 Woodward Pharma Recent Developments/Updates
6.2 Amarin Pharmaceuticals
6.2.1 Amarin Pharmaceuticals Company Information
6.2.2 Amarin Pharmaceuticals Description and Business Overview
6.2.3 Amarin Pharmaceuticals Omega-3 Fatty Acid Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Amarin Pharmaceuticals Omega-3 Fatty Acid Drugs Product Portfolio
6.2.5 Amarin Pharmaceuticals Recent Developments/Updates
6.3 Apotex
6.3.1 Apotex Company Information
6.3.2 Apotex Description and Business Overview
6.3.3 Apotex Omega-3 Fatty Acid Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Apotex Omega-3 Fatty Acid Drugs Product Portfolio
6.3.5 Apotex Recent Developments/Updates
6.4 Hikma
6.4.1 Hikma Company Information
6.4.2 Hikma Description and Business Overview
6.4.3 Hikma Omega-3 Fatty Acid Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Hikma Omega-3 Fatty Acid Drugs Product Portfolio
6.4.5 Hikma Recent Developments/Updates
6.5 Dr. Reddy's Laboratories
6.5.1 Dr. Reddy's Laboratories Company Information
6.5.2 Dr. Reddy's Laboratories Description and Business Overview
6.5.3 Dr. Reddy's Laboratories Omega-3 Fatty Acid Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Dr. Reddy's Laboratories Omega-3 Fatty Acid Drugs Product Portfolio
6.5.5 Dr. Reddy's Laboratories Recent Developments/Updates
6.6 Teva
6.6.1 Teva Company Information
6.6.2 Teva Description and Business Overview
6.6.3 Teva Omega-3 Fatty Acid Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Teva Omega-3 Fatty Acid Drugs Product Portfolio
6.6.5 Teva Recent Developments/Updates
6.7 Ascent Pharmaceuticals
6.7.1 Ascent Pharmaceuticals Company Information
6.7.2 Ascent Pharmaceuticals Description and Business Overview
6.7.3 Ascent Pharmaceuticals Omega-3 Fatty Acid Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Ascent Pharmaceuticals Omega-3 Fatty Acid Drugs Product Portfolio
6.7.5 Ascent Pharmaceuticals Recent Developments/Updates
6.8 Zydus
6.8.1 Zydus Company Information
6.8.2 Zydus Description and Business Overview
6.8.3 Zydus Omega-3 Fatty Acid Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Zydus Omega-3 Fatty Acid Drugs Product Portfolio
6.8.5 Zydus Recent Developments/Updates
6.9 Strides Pharma
6.9.1 Strides Pharma Company Information
6.9.2 Strides Pharma Description and Business Overview
6.9.3 Strides Pharma Omega-3 Fatty Acid Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Strides Pharma Omega-3 Fatty Acid Drugs Product Portfolio
6.9.5 Strides Pharma Recent Developments/Updates
6.10 PuraCap Pharmaceuticals
6.10.1 PuraCap Pharmaceuticals Company Information
6.10.2 PuraCap Pharmaceuticals Description and Business Overview
6.10.3 PuraCap Pharmaceuticals Omega-3 Fatty Acid Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 PuraCap Pharmaceuticals Omega-3 Fatty Acid Drugs Product Portfolio
6.10.5 PuraCap Pharmaceuticals Recent Developments/Updates
6.11 Sun Pharma
6.11.1 Sun Pharma Company Information
6.11.2 Sun Pharma Description and Business Overview
6.11.3 Sun Pharma Omega-3 Fatty Acid Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Sun Pharma Omega-3 Fatty Acid Drugs Product Portfolio
6.11.5 Sun Pharma Recent Developments/Updates
6.12 Mankind Pharma
6.12.1 Mankind Pharma Company Information
6.12.2 Mankind Pharma Description and Business Overview
6.12.3 Mankind Pharma Omega-3 Fatty Acid Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Mankind Pharma Omega-3 Fatty Acid Drugs Product Portfolio
6.12.5 Mankind Pharma Recent Developments/Updates
6.13 Amneal Pharmaceuticals
6.13.1 Amneal Pharmaceuticals Company Information
6.13.2 Amneal Pharmaceuticals Description and Business Overview
6.13.3 Amneal Pharmaceuticals Omega-3 Fatty Acid Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Amneal Pharmaceuticals Omega-3 Fatty Acid Drugs Product Portfolio
6.13.5 Amneal Pharmaceuticals Recent Developments/Updates
6.14 GLW Pharma
6.14.1 GLW Pharma Company Information
6.14.2 GLW Pharma Description and Business Overview
6.14.3 GLW Pharma Omega-3 Fatty Acid Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 GLW Pharma Omega-3 Fatty Acid Drugs Product Portfolio
6.14.5 GLW Pharma Recent Developments/Updates
6.15 Sichuan Gowell Pharmaceutical
6.15.1 Sichuan Gowell Pharmaceutical Company Information
6.15.2 Sichuan Gowell Pharmaceutical Description and Business Overview
6.15.3 Sichuan Gowell Pharmaceutical Omega-3 Fatty Acid Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Sichuan Gowell Pharmaceutical Omega-3 Fatty Acid Drugs Product Portfolio
6.15.5 Sichuan Gowell Pharmaceutical Recent Developments/Updates
6.16 Qilu Pharmaceutical
6.16.1 Qilu Pharmaceutical Company Information
6.16.2 Qilu Pharmaceutical Description and Business Overview
6.16.3 Qilu Pharmaceutical Omega-3 Fatty Acid Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 Qilu Pharmaceutical Omega-3 Fatty Acid Drugs Product Portfolio
6.16.5 Qilu Pharmaceutical Recent Developments/Updates
6.17 Chengdu Suncadia Medicine
6.17.1 Chengdu Suncadia Medicine Company Information
6.17.2 Chengdu Suncadia Medicine Description and Business Overview
6.17.3 Chengdu Suncadia Medicine Omega-3 Fatty Acid Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 Chengdu Suncadia Medicine Omega-3 Fatty Acid Drugs Product Portfolio
6.17.5 Chengdu Suncadia Medicine Recent Developments/Updates
6.18 Jiangsu Wangao Pharmaceutical
6.18.1 Jiangsu Wangao Pharmaceutical Company Information
6.18.2 Jiangsu Wangao Pharmaceutical Description and Business Overview
6.18.3 Jiangsu Wangao Pharmaceutical Omega-3 Fatty Acid Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.18.4 Jiangsu Wangao Pharmaceutical Omega-3 Fatty Acid Drugs Product Portfolio
6.18.5 Jiangsu Wangao Pharmaceutical Recent Developments/Updates
6.19 Humanwell Puracap Pharmaceuticals
6.19.1 Humanwell Puracap Pharmaceuticals Company Information
6.19.2 Humanwell Puracap Pharmaceuticals Description and Business Overview
6.19.3 Humanwell Puracap Pharmaceuticals Omega-3 Fatty Acid Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.19.4 Humanwell Puracap Pharmaceuticals Omega-3 Fatty Acid Drugs Product Portfolio
6.19.5 Humanwell Puracap Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Omega-3 Fatty Acid Drugs Industry Chain Analysis
7.2 Omega-3 Fatty Acid Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Omega-3 Fatty Acid Drugs Production Mode & Process Analysis
7.4 Omega-3 Fatty Acid Drugs Sales and Marketing
7.4.1 Omega-3 Fatty Acid Drugs Sales Channels
7.4.2 Omega-3 Fatty Acid Drugs Distributors
7.5 Omega-3 Fatty Acid Drugs Customer Analysis
8 Omega-3 Fatty Acid Drugs Market Dynamics
8.1 Omega-3 Fatty Acid Drugs Industry Trends
8.2 Omega-3 Fatty Acid Drugs Market Drivers
8.3 Omega-3 Fatty Acid Drugs Market Challenges
8.4 Omega-3 Fatty Acid Drugs Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Omega-3 Fatty Acid Drugs by Type
1.2.1 Global Omega-3 Fatty Acid Drugs Market Value by Type: 2025 vs 2032
1.2.2 EPA
1.2.3 EPA and DHA
1.3 Omega-3 Fatty Acid Drugs by Application
1.3.1 Global Omega-3 Fatty Acid Drugs Market Value by Application: 2025 vs 2032
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 Global Omega-3 Fatty Acid Drugs Market Size Estimates and Forecasts
1.4.1 Global Omega-3 Fatty Acid Drugs Revenue 2021–2032
1.4.2 Global Omega-3 Fatty Acid Drugs Sales 2021–2032
1.4.3 Global Omega-3 Fatty Acid Drugs Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Omega-3 Fatty Acid Drugs Market Competition by Manufacturers
2.1 Global Omega-3 Fatty Acid Drugs Sales Market Share by Manufacturers (2021–2026)
2.2 Global Omega-3 Fatty Acid Drugs Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Omega-3 Fatty Acid Drugs Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Omega-3 Fatty Acid Drugs, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Omega-3 Fatty Acid Drugs, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Omega-3 Fatty Acid Drugs, Product Types and Applications
2.7 Global Key Manufacturers of Omega-3 Fatty Acid Drugs, Date of Entry into the Industry
2.8 Global Omega-3 Fatty Acid Drugs Market Competitive Situation and Trends
2.8.1 Global Omega-3 Fatty Acid Drugs Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Omega-3 Fatty Acid Drugs Players Market Share by Revenue
2.8.3 Global Omega-3 Fatty Acid Drugs Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Omega-3 Fatty Acid Drugs Market Scenario by Region
3.1 Global Omega-3 Fatty Acid Drugs Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Omega-3 Fatty Acid Drugs Sales by Region: 2021–2032
3.2.1 Global Omega-3 Fatty Acid Drugs Sales by Region: 2021–2026
3.2.2 Global Omega-3 Fatty Acid Drugs Sales by Region: 2027–2032
3.3 Global Omega-3 Fatty Acid Drugs Revenue by Region: 2021–2032
3.3.1 Global Omega-3 Fatty Acid Drugs Revenue by Region: 2021–2026
3.3.2 Global Omega-3 Fatty Acid Drugs Revenue by Region: 2027–2032
3.4 North America Omega-3 Fatty Acid Drugs Market Facts & Figures by Country
3.4.1 North America Omega-3 Fatty Acid Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Omega-3 Fatty Acid Drugs Sales by Country (2021–2032)
3.4.3 North America Omega-3 Fatty Acid Drugs Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Omega-3 Fatty Acid Drugs Market Facts & Figures by Country
3.5.1 Europe Omega-3 Fatty Acid Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Omega-3 Fatty Acid Drugs Sales by Country (2021–2032)
3.5.3 Europe Omega-3 Fatty Acid Drugs Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Omega-3 Fatty Acid Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Omega-3 Fatty Acid Drugs Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Omega-3 Fatty Acid Drugs Sales by Region (2021–2032)
3.6.3 Asia Pacific Omega-3 Fatty Acid Drugs Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Omega-3 Fatty Acid Drugs Market Facts & Figures by Country
3.7.1 Latin America Omega-3 Fatty Acid Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Omega-3 Fatty Acid Drugs Sales by Country (2021–2032)
3.7.3 Latin America Omega-3 Fatty Acid Drugs Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Omega-3 Fatty Acid Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Omega-3 Fatty Acid Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Omega-3 Fatty Acid Drugs Sales by Country (2021–2032)
3.8.3 Middle East and Africa Omega-3 Fatty Acid Drugs Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Omega-3 Fatty Acid Drugs Sales by Type (2021–2032)
4.1.1 Global Omega-3 Fatty Acid Drugs Sales by Type (2021–2026)
4.1.2 Global Omega-3 Fatty Acid Drugs Sales by Type (2027–2032)
4.1.3 Global Omega-3 Fatty Acid Drugs Sales Market Share by Type (2021–2032)
4.2 Global Omega-3 Fatty Acid Drugs Revenue by Type (2021–2032)
4.2.1 Global Omega-3 Fatty Acid Drugs Revenue by Type (2021–2026)
4.2.2 Global Omega-3 Fatty Acid Drugs Revenue by Type (2027–2032)
4.2.3 Global Omega-3 Fatty Acid Drugs Revenue Market Share by Type (2021–2032)
4.3 Global Omega-3 Fatty Acid Drugs Price by Type (2021–2032)
5 Segment by Application
5.1 Global Omega-3 Fatty Acid Drugs Sales by Application (2021–2032)
5.1.1 Global Omega-3 Fatty Acid Drugs Sales by Application (2021–2026)
5.1.2 Global Omega-3 Fatty Acid Drugs Sales by Application (2027–2032)
5.1.3 Global Omega-3 Fatty Acid Drugs Sales Market Share by Application (2021–2032)
5.2 Global Omega-3 Fatty Acid Drugs Revenue by Application (2021–2032)
5.2.1 Global Omega-3 Fatty Acid Drugs Revenue by Application (2021–2026)
5.2.2 Global Omega-3 Fatty Acid Drugs Revenue by Application (2027–2032)
5.2.3 Global Omega-3 Fatty Acid Drugs Revenue Market Share by Application (2021–2032)
5.3 Global Omega-3 Fatty Acid Drugs Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Woodward Pharma
6.1.1 Woodward Pharma Company Information
6.1.2 Woodward Pharma Description and Business Overview
6.1.3 Woodward Pharma Omega-3 Fatty Acid Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Woodward Pharma Omega-3 Fatty Acid Drugs Product Portfolio
6.1.5 Woodward Pharma Recent Developments/Updates
6.2 Amarin Pharmaceuticals
6.2.1 Amarin Pharmaceuticals Company Information
6.2.2 Amarin Pharmaceuticals Description and Business Overview
6.2.3 Amarin Pharmaceuticals Omega-3 Fatty Acid Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Amarin Pharmaceuticals Omega-3 Fatty Acid Drugs Product Portfolio
6.2.5 Amarin Pharmaceuticals Recent Developments/Updates
6.3 Apotex
6.3.1 Apotex Company Information
6.3.2 Apotex Description and Business Overview
6.3.3 Apotex Omega-3 Fatty Acid Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Apotex Omega-3 Fatty Acid Drugs Product Portfolio
6.3.5 Apotex Recent Developments/Updates
6.4 Hikma
6.4.1 Hikma Company Information
6.4.2 Hikma Description and Business Overview
6.4.3 Hikma Omega-3 Fatty Acid Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Hikma Omega-3 Fatty Acid Drugs Product Portfolio
6.4.5 Hikma Recent Developments/Updates
6.5 Dr. Reddy's Laboratories
6.5.1 Dr. Reddy's Laboratories Company Information
6.5.2 Dr. Reddy's Laboratories Description and Business Overview
6.5.3 Dr. Reddy's Laboratories Omega-3 Fatty Acid Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Dr. Reddy's Laboratories Omega-3 Fatty Acid Drugs Product Portfolio
6.5.5 Dr. Reddy's Laboratories Recent Developments/Updates
6.6 Teva
6.6.1 Teva Company Information
6.6.2 Teva Description and Business Overview
6.6.3 Teva Omega-3 Fatty Acid Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Teva Omega-3 Fatty Acid Drugs Product Portfolio
6.6.5 Teva Recent Developments/Updates
6.7 Ascent Pharmaceuticals
6.7.1 Ascent Pharmaceuticals Company Information
6.7.2 Ascent Pharmaceuticals Description and Business Overview
6.7.3 Ascent Pharmaceuticals Omega-3 Fatty Acid Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Ascent Pharmaceuticals Omega-3 Fatty Acid Drugs Product Portfolio
6.7.5 Ascent Pharmaceuticals Recent Developments/Updates
6.8 Zydus
6.8.1 Zydus Company Information
6.8.2 Zydus Description and Business Overview
6.8.3 Zydus Omega-3 Fatty Acid Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Zydus Omega-3 Fatty Acid Drugs Product Portfolio
6.8.5 Zydus Recent Developments/Updates
6.9 Strides Pharma
6.9.1 Strides Pharma Company Information
6.9.2 Strides Pharma Description and Business Overview
6.9.3 Strides Pharma Omega-3 Fatty Acid Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Strides Pharma Omega-3 Fatty Acid Drugs Product Portfolio
6.9.5 Strides Pharma Recent Developments/Updates
6.10 PuraCap Pharmaceuticals
6.10.1 PuraCap Pharmaceuticals Company Information
6.10.2 PuraCap Pharmaceuticals Description and Business Overview
6.10.3 PuraCap Pharmaceuticals Omega-3 Fatty Acid Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 PuraCap Pharmaceuticals Omega-3 Fatty Acid Drugs Product Portfolio
6.10.5 PuraCap Pharmaceuticals Recent Developments/Updates
6.11 Sun Pharma
6.11.1 Sun Pharma Company Information
6.11.2 Sun Pharma Description and Business Overview
6.11.3 Sun Pharma Omega-3 Fatty Acid Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Sun Pharma Omega-3 Fatty Acid Drugs Product Portfolio
6.11.5 Sun Pharma Recent Developments/Updates
6.12 Mankind Pharma
6.12.1 Mankind Pharma Company Information
6.12.2 Mankind Pharma Description and Business Overview
6.12.3 Mankind Pharma Omega-3 Fatty Acid Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Mankind Pharma Omega-3 Fatty Acid Drugs Product Portfolio
6.12.5 Mankind Pharma Recent Developments/Updates
6.13 Amneal Pharmaceuticals
6.13.1 Amneal Pharmaceuticals Company Information
6.13.2 Amneal Pharmaceuticals Description and Business Overview
6.13.3 Amneal Pharmaceuticals Omega-3 Fatty Acid Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Amneal Pharmaceuticals Omega-3 Fatty Acid Drugs Product Portfolio
6.13.5 Amneal Pharmaceuticals Recent Developments/Updates
6.14 GLW Pharma
6.14.1 GLW Pharma Company Information
6.14.2 GLW Pharma Description and Business Overview
6.14.3 GLW Pharma Omega-3 Fatty Acid Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 GLW Pharma Omega-3 Fatty Acid Drugs Product Portfolio
6.14.5 GLW Pharma Recent Developments/Updates
6.15 Sichuan Gowell Pharmaceutical
6.15.1 Sichuan Gowell Pharmaceutical Company Information
6.15.2 Sichuan Gowell Pharmaceutical Description and Business Overview
6.15.3 Sichuan Gowell Pharmaceutical Omega-3 Fatty Acid Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Sichuan Gowell Pharmaceutical Omega-3 Fatty Acid Drugs Product Portfolio
6.15.5 Sichuan Gowell Pharmaceutical Recent Developments/Updates
6.16 Qilu Pharmaceutical
6.16.1 Qilu Pharmaceutical Company Information
6.16.2 Qilu Pharmaceutical Description and Business Overview
6.16.3 Qilu Pharmaceutical Omega-3 Fatty Acid Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 Qilu Pharmaceutical Omega-3 Fatty Acid Drugs Product Portfolio
6.16.5 Qilu Pharmaceutical Recent Developments/Updates
6.17 Chengdu Suncadia Medicine
6.17.1 Chengdu Suncadia Medicine Company Information
6.17.2 Chengdu Suncadia Medicine Description and Business Overview
6.17.3 Chengdu Suncadia Medicine Omega-3 Fatty Acid Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 Chengdu Suncadia Medicine Omega-3 Fatty Acid Drugs Product Portfolio
6.17.5 Chengdu Suncadia Medicine Recent Developments/Updates
6.18 Jiangsu Wangao Pharmaceutical
6.18.1 Jiangsu Wangao Pharmaceutical Company Information
6.18.2 Jiangsu Wangao Pharmaceutical Description and Business Overview
6.18.3 Jiangsu Wangao Pharmaceutical Omega-3 Fatty Acid Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.18.4 Jiangsu Wangao Pharmaceutical Omega-3 Fatty Acid Drugs Product Portfolio
6.18.5 Jiangsu Wangao Pharmaceutical Recent Developments/Updates
6.19 Humanwell Puracap Pharmaceuticals
6.19.1 Humanwell Puracap Pharmaceuticals Company Information
6.19.2 Humanwell Puracap Pharmaceuticals Description and Business Overview
6.19.3 Humanwell Puracap Pharmaceuticals Omega-3 Fatty Acid Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.19.4 Humanwell Puracap Pharmaceuticals Omega-3 Fatty Acid Drugs Product Portfolio
6.19.5 Humanwell Puracap Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Omega-3 Fatty Acid Drugs Industry Chain Analysis
7.2 Omega-3 Fatty Acid Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Omega-3 Fatty Acid Drugs Production Mode & Process Analysis
7.4 Omega-3 Fatty Acid Drugs Sales and Marketing
7.4.1 Omega-3 Fatty Acid Drugs Sales Channels
7.4.2 Omega-3 Fatty Acid Drugs Distributors
7.5 Omega-3 Fatty Acid Drugs Customer Analysis
8 Omega-3 Fatty Acid Drugs Market Dynamics
8.1 Omega-3 Fatty Acid Drugs Industry Trends
8.2 Omega-3 Fatty Acid Drugs Market Drivers
8.3 Omega-3 Fatty Acid Drugs Market Challenges
8.4 Omega-3 Fatty Acid Drugs Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Omega-3 Fatty Acid Drugs Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Omega-3 Fatty Acid Drugs Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Omega-3 Fatty Acid Drugs Market Competitive Situation by Manufacturers in 2025
Table 4. Global Omega-3 Fatty Acid Drugs Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Omega-3 Fatty Acid Drugs Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Omega-3 Fatty Acid Drugs Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Omega-3 Fatty Acid Drugs Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Omega-3 Fatty Acid Drugs Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Omega-3 Fatty Acid Drugs, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Omega-3 Fatty Acid Drugs, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Omega-3 Fatty Acid Drugs, Product Types and Applications
Table 12. Global Key Manufacturers of Omega-3 Fatty Acid Drugs, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Omega-3 Fatty Acid Drugs Companies by Tier (Tier 1, Tier 2, Tier 3), based on Omega-3 Fatty Acid Drugs Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Omega-3 Fatty Acid Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Omega-3 Fatty Acid Drugs Sales by Region (K Units), 2021–2026
Table 18. Global Omega-3 Fatty Acid Drugs Sales Market Share by Region (2021–2026)
Table 19. Global Omega-3 Fatty Acid Drugs Sales by Region (K Units), 2027–2032
Table 20. Global Omega-3 Fatty Acid Drugs Sales Market Share by Region (2027–2032)
Table 21. Global Omega-3 Fatty Acid Drugs Revenue by Region (US$ Million), 2021–2026
Table 22. Global Omega-3 Fatty Acid Drugs Revenue Market Share by Region (2021–2026)
Table 23. Global Omega-3 Fatty Acid Drugs Revenue by Region (US$ Million), 2027–2032
Table 24. Global Omega-3 Fatty Acid Drugs Revenue Market Share by Region (2027–2032)
Table 25. North America Omega-3 Fatty Acid Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Omega-3 Fatty Acid Drugs Sales by Country (K Units), 2021–2026
Table 27. North America Omega-3 Fatty Acid Drugs Sales by Country (K Units), 2027–2032
Table 28. North America Omega-3 Fatty Acid Drugs Revenue by Country (US$ Million), 2021–2026
Table 29. North America Omega-3 Fatty Acid Drugs Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Omega-3 Fatty Acid Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Omega-3 Fatty Acid Drugs Sales by Country (K Units), 2021–2026
Table 32. Europe Omega-3 Fatty Acid Drugs Sales by Country (K Units), 2027–2032
Table 33. Europe Omega-3 Fatty Acid Drugs Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Omega-3 Fatty Acid Drugs Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Omega-3 Fatty Acid Drugs Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Omega-3 Fatty Acid Drugs Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Omega-3 Fatty Acid Drugs Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Omega-3 Fatty Acid Drugs Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Omega-3 Fatty Acid Drugs Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Omega-3 Fatty Acid Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Omega-3 Fatty Acid Drugs Sales by Country (K Units), 2021–2026
Table 42. Latin America Omega-3 Fatty Acid Drugs Sales by Country (K Units), 2027–2032
Table 43. Latin America Omega-3 Fatty Acid Drugs Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Omega-3 Fatty Acid Drugs Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Omega-3 Fatty Acid Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Omega-3 Fatty Acid Drugs Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Omega-3 Fatty Acid Drugs Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Omega-3 Fatty Acid Drugs Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Omega-3 Fatty Acid Drugs Revenue by Country (US$ Million), 2027–2032
Table 50. Global Omega-3 Fatty Acid Drugs Sales (K Units) by Type (2021–2026)
Table 51. Global Omega-3 Fatty Acid Drugs Sales (K Units) by Type (2027–2032)
Table 52. Global Omega-3 Fatty Acid Drugs Sales Market Share by Type (2021–2026)
Table 53. Global Omega-3 Fatty Acid Drugs Sales Market Share by Type (2027–2032)
Table 54. Global Omega-3 Fatty Acid Drugs Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Omega-3 Fatty Acid Drugs Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Omega-3 Fatty Acid Drugs Revenue Market Share by Type (2021–2026)
Table 57. Global Omega-3 Fatty Acid Drugs Revenue Market Share by Type (2027–2032)
Table 58. Global Omega-3 Fatty Acid Drugs Price (US$/Unit) by Type (2021–2026)
Table 59. Global Omega-3 Fatty Acid Drugs Price (US$/Unit) by Type (2027–2032)
Table 60. Global Omega-3 Fatty Acid Drugs Sales (K Units) by Application (2021–2026)
Table 61. Global Omega-3 Fatty Acid Drugs Sales (K Units) by Application (2027–2032)
Table 62. Global Omega-3 Fatty Acid Drugs Sales Market Share by Application (2021–2026)
Table 63. Global Omega-3 Fatty Acid Drugs Sales Market Share by Application (2027–2032)
Table 64. Global Omega-3 Fatty Acid Drugs Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Omega-3 Fatty Acid Drugs Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Omega-3 Fatty Acid Drugs Revenue Market Share by Application (2021–2026)
Table 67. Global Omega-3 Fatty Acid Drugs Revenue Market Share by Application (2027–2032)
Table 68. Global Omega-3 Fatty Acid Drugs Price (US$/Unit) by Application (2021–2026)
Table 69. Global Omega-3 Fatty Acid Drugs Price (US$/Unit) by Application (2027–2032)
Table 70. Woodward Pharma Company Information
Table 71. Woodward Pharma Description and Business Overview
Table 72. Woodward Pharma Omega-3 Fatty Acid Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Woodward Pharma Omega-3 Fatty Acid Drugs Product
Table 74. Woodward Pharma Recent Developments/Updates
Table 75. Amarin Pharmaceuticals Company Information
Table 76. Amarin Pharmaceuticals Description and Business Overview
Table 77. Amarin Pharmaceuticals Omega-3 Fatty Acid Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Amarin Pharmaceuticals Omega-3 Fatty Acid Drugs Product
Table 79. Amarin Pharmaceuticals Recent Developments/Updates
Table 80. Apotex Company Information
Table 81. Apotex Description and Business Overview
Table 82. Apotex Omega-3 Fatty Acid Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Apotex Omega-3 Fatty Acid Drugs Product
Table 84. Apotex Recent Developments/Updates
Table 85. Hikma Company Information
Table 86. Hikma Description and Business Overview
Table 87. Hikma Omega-3 Fatty Acid Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Hikma Omega-3 Fatty Acid Drugs Product
Table 89. Hikma Recent Developments/Updates
Table 90. Dr. Reddy's Laboratories Company Information
Table 91. Dr. Reddy's Laboratories Description and Business Overview
Table 92. Dr. Reddy's Laboratories Omega-3 Fatty Acid Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Dr. Reddy's Laboratories Omega-3 Fatty Acid Drugs Product
Table 94. Dr. Reddy's Laboratories Recent Developments/Updates
Table 95. Teva Company Information
Table 96. Teva Description and Business Overview
Table 97. Teva Omega-3 Fatty Acid Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Teva Omega-3 Fatty Acid Drugs Product
Table 99. Teva Recent Developments/Updates
Table 100. Ascent Pharmaceuticals Company Information
Table 101. Ascent Pharmaceuticals Description and Business Overview
Table 102. Ascent Pharmaceuticals Omega-3 Fatty Acid Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Ascent Pharmaceuticals Omega-3 Fatty Acid Drugs Product
Table 104. Ascent Pharmaceuticals Recent Developments/Updates
Table 105. Zydus Company Information
Table 106. Zydus Description and Business Overview
Table 107. Zydus Omega-3 Fatty Acid Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Zydus Omega-3 Fatty Acid Drugs Product
Table 109. Zydus Recent Developments/Updates
Table 110. Strides Pharma Company Information
Table 111. Strides Pharma Description and Business Overview
Table 112. Strides Pharma Omega-3 Fatty Acid Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Strides Pharma Omega-3 Fatty Acid Drugs Product
Table 114. Strides Pharma Recent Developments/Updates
Table 115. PuraCap Pharmaceuticals Company Information
Table 116. PuraCap Pharmaceuticals Description and Business Overview
Table 117. PuraCap Pharmaceuticals Omega-3 Fatty Acid Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. PuraCap Pharmaceuticals Omega-3 Fatty Acid Drugs Product
Table 119. PuraCap Pharmaceuticals Recent Developments/Updates
Table 120. Sun Pharma Company Information
Table 121. Sun Pharma Description and Business Overview
Table 122. Sun Pharma Omega-3 Fatty Acid Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Sun Pharma Omega-3 Fatty Acid Drugs Product
Table 124. Sun Pharma Recent Developments/Updates
Table 125. Mankind Pharma Company Information
Table 126. Mankind Pharma Description and Business Overview
Table 127. Mankind Pharma Omega-3 Fatty Acid Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. Mankind Pharma Omega-3 Fatty Acid Drugs Product
Table 129. Mankind Pharma Recent Developments/Updates
Table 130. Amneal Pharmaceuticals Company Information
Table 131. Amneal Pharmaceuticals Description and Business Overview
Table 132. Amneal Pharmaceuticals Omega-3 Fatty Acid Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 133. Amneal Pharmaceuticals Omega-3 Fatty Acid Drugs Product
Table 134. Amneal Pharmaceuticals Recent Developments/Updates
Table 135. GLW Pharma Company Information
Table 136. GLW Pharma Description and Business Overview
Table 137. GLW Pharma Omega-3 Fatty Acid Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 138. GLW Pharma Omega-3 Fatty Acid Drugs Product
Table 139. GLW Pharma Recent Developments/Updates
Table 140. Sichuan Gowell Pharmaceutical Company Information
Table 141. Sichuan Gowell Pharmaceutical Description and Business Overview
Table 142. Sichuan Gowell Pharmaceutical Omega-3 Fatty Acid Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 143. Sichuan Gowell Pharmaceutical Omega-3 Fatty Acid Drugs Product
Table 144. Sichuan Gowell Pharmaceutical Recent Developments/Updates
Table 145. Qilu Pharmaceutical Company Information
Table 146. Qilu Pharmaceutical Description and Business Overview
Table 147. Qilu Pharmaceutical Omega-3 Fatty Acid Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 148. Qilu Pharmaceutical Omega-3 Fatty Acid Drugs Product
Table 149. Qilu Pharmaceutical Recent Developments/Updates
Table 150. Chengdu Suncadia Medicine Company Information
Table 151. Chengdu Suncadia Medicine Description and Business Overview
Table 152. Chengdu Suncadia Medicine Omega-3 Fatty Acid Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 153. Chengdu Suncadia Medicine Omega-3 Fatty Acid Drugs Product
Table 154. Chengdu Suncadia Medicine Recent Developments/Updates
Table 155. Jiangsu Wangao Pharmaceutical Company Information
Table 156. Jiangsu Wangao Pharmaceutical Description and Business Overview
Table 157. Jiangsu Wangao Pharmaceutical Omega-3 Fatty Acid Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 158. Jiangsu Wangao Pharmaceutical Omega-3 Fatty Acid Drugs Product
Table 159. Jiangsu Wangao Pharmaceutical Recent Developments/Updates
Table 160. Humanwell Puracap Pharmaceuticals Company Information
Table 161. Humanwell Puracap Pharmaceuticals Description and Business Overview
Table 162. Humanwell Puracap Pharmaceuticals Omega-3 Fatty Acid Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 163. Humanwell Puracap Pharmaceuticals Omega-3 Fatty Acid Drugs Product
Table 164. Humanwell Puracap Pharmaceuticals Recent Developments/Updates
Table 165. Key Raw Materials Lists
Table 166. Raw Materials Key Suppliers Lists
Table 167. Omega-3 Fatty Acid Drugs Distributors List
Table 168. Omega-3 Fatty Acid Drugs Customers List
Table 169. Omega-3 Fatty Acid Drugs Market Trends
Table 170. Omega-3 Fatty Acid Drugs Market Drivers
Table 171. Omega-3 Fatty Acid Drugs Market Challenges
Table 172. Omega-3 Fatty Acid Drugs Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
Table 176. Authors List of This Report
List of Figures
Figure 1. Product Picture of Omega-3 Fatty Acid Drugs
Figure 2. Global Omega-3 Fatty Acid Drugs Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Omega-3 Fatty Acid Drugs Market Share by Type: 2025 & 2032
Figure 4. EPA Product Picture
Figure 5. EPA and DHA Product Picture
Figure 6. Global Omega-3 Fatty Acid Drugs Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Omega-3 Fatty Acid Drugs Market Share by Application: 2025 & 2032
Figure 8. Hospital Pharmacy
Figure 9. Retail Pharmacy
Figure 10. Online Pharmacy
Figure 11. Global Omega-3 Fatty Acid Drugs Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global Omega-3 Fatty Acid Drugs Market Size (US$ Million), 2021–2032
Figure 13. Global Omega-3 Fatty Acid Drugs Sales (K Units), 2021–2032
Figure 14. Global Omega-3 Fatty Acid Drugs Average Price (US$/Unit), 2021–2032
Figure 15. Omega-3 Fatty Acid Drugs Report Years Considered
Figure 16. Omega-3 Fatty Acid Drugs Sales Share by Manufacturers in 2025
Figure 17. Global Omega-3 Fatty Acid Drugs Revenue Share by Manufacturers in 2025
Figure 18. Top 5 and Top 10 Global Omega-3 Fatty Acid Drugs Players: Market Share by Revenue in Omega-3 Fatty Acid Drugs in 2025
Figure 19. Omega-3 Fatty Acid Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 20. Global Omega-3 Fatty Acid Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 21. North America Omega-3 Fatty Acid Drugs Sales Market Share by Country (2021–2032)
Figure 22. North America Omega-3 Fatty Acid Drugs Revenue Market Share by Country (2021–2032)
Figure 23. United States Omega-3 Fatty Acid Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Canada Omega-3 Fatty Acid Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Europe Omega-3 Fatty Acid Drugs Sales Market Share by Country (2021–2032)
Figure 26. Europe Omega-3 Fatty Acid Drugs Revenue Market Share by Country (2021–2032)
Figure 27. Germany Omega-3 Fatty Acid Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. France Omega-3 Fatty Acid Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. U.K. Omega-3 Fatty Acid Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Italy Omega-3 Fatty Acid Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Russia Omega-3 Fatty Acid Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Asia Pacific Omega-3 Fatty Acid Drugs Sales Market Share by Region (2021–2032)
Figure 33. Asia Pacific Omega-3 Fatty Acid Drugs Revenue Market Share by Region (2021–2032)
Figure 34. China Omega-3 Fatty Acid Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Japan Omega-3 Fatty Acid Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. South Korea Omega-3 Fatty Acid Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. India Omega-3 Fatty Acid Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Australia Omega-3 Fatty Acid Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. China Taiwan Omega-3 Fatty Acid Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Southeast Asia Omega-3 Fatty Acid Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Latin America Omega-3 Fatty Acid Drugs Sales Market Share by Country (2021–2032)
Figure 42. Latin America Omega-3 Fatty Acid Drugs Revenue Market Share by Country (2021–2032)
Figure 43. Mexico Omega-3 Fatty Acid Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Brazil Omega-3 Fatty Acid Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Argentina Omega-3 Fatty Acid Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Colombia Omega-3 Fatty Acid Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Middle East and Africa Omega-3 Fatty Acid Drugs Sales Market Share by Country (2021–2032)
Figure 48. Middle East and Africa Omega-3 Fatty Acid Drugs Revenue Market Share by Country (2021–2032)
Figure 49. Turkey Omega-3 Fatty Acid Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Saudi Arabia Omega-3 Fatty Acid Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. UAE Omega-3 Fatty Acid Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Global Sales Market Share of Omega-3 Fatty Acid Drugs by Type (2021–2032)
Figure 53. Global Revenue Market Share of Omega-3 Fatty Acid Drugs by Type (2021–2032)
Figure 54. Global Omega-3 Fatty Acid Drugs Price (US$/Unit) by Type (2021–2032)
Figure 55. Global Sales Market Share of Omega-3 Fatty Acid Drugs by Application (2021–2032)
Figure 56. Global Revenue Market Share of Omega-3 Fatty Acid Drugs by Application (2021–2032)
Figure 57. Global Omega-3 Fatty Acid Drugs Price (US$/Unit) by Application (2021–2032)
Figure 58. Omega-3 Fatty Acid Drugs Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Table 1. Global Omega-3 Fatty Acid Drugs Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Omega-3 Fatty Acid Drugs Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Omega-3 Fatty Acid Drugs Market Competitive Situation by Manufacturers in 2025
Table 4. Global Omega-3 Fatty Acid Drugs Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Omega-3 Fatty Acid Drugs Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Omega-3 Fatty Acid Drugs Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Omega-3 Fatty Acid Drugs Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Omega-3 Fatty Acid Drugs Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Omega-3 Fatty Acid Drugs, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Omega-3 Fatty Acid Drugs, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Omega-3 Fatty Acid Drugs, Product Types and Applications
Table 12. Global Key Manufacturers of Omega-3 Fatty Acid Drugs, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Omega-3 Fatty Acid Drugs Companies by Tier (Tier 1, Tier 2, Tier 3), based on Omega-3 Fatty Acid Drugs Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Omega-3 Fatty Acid Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Omega-3 Fatty Acid Drugs Sales by Region (K Units), 2021–2026
Table 18. Global Omega-3 Fatty Acid Drugs Sales Market Share by Region (2021–2026)
Table 19. Global Omega-3 Fatty Acid Drugs Sales by Region (K Units), 2027–2032
Table 20. Global Omega-3 Fatty Acid Drugs Sales Market Share by Region (2027–2032)
Table 21. Global Omega-3 Fatty Acid Drugs Revenue by Region (US$ Million), 2021–2026
Table 22. Global Omega-3 Fatty Acid Drugs Revenue Market Share by Region (2021–2026)
Table 23. Global Omega-3 Fatty Acid Drugs Revenue by Region (US$ Million), 2027–2032
Table 24. Global Omega-3 Fatty Acid Drugs Revenue Market Share by Region (2027–2032)
Table 25. North America Omega-3 Fatty Acid Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Omega-3 Fatty Acid Drugs Sales by Country (K Units), 2021–2026
Table 27. North America Omega-3 Fatty Acid Drugs Sales by Country (K Units), 2027–2032
Table 28. North America Omega-3 Fatty Acid Drugs Revenue by Country (US$ Million), 2021–2026
Table 29. North America Omega-3 Fatty Acid Drugs Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Omega-3 Fatty Acid Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Omega-3 Fatty Acid Drugs Sales by Country (K Units), 2021–2026
Table 32. Europe Omega-3 Fatty Acid Drugs Sales by Country (K Units), 2027–2032
Table 33. Europe Omega-3 Fatty Acid Drugs Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Omega-3 Fatty Acid Drugs Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Omega-3 Fatty Acid Drugs Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Omega-3 Fatty Acid Drugs Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Omega-3 Fatty Acid Drugs Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Omega-3 Fatty Acid Drugs Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Omega-3 Fatty Acid Drugs Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Omega-3 Fatty Acid Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Omega-3 Fatty Acid Drugs Sales by Country (K Units), 2021–2026
Table 42. Latin America Omega-3 Fatty Acid Drugs Sales by Country (K Units), 2027–2032
Table 43. Latin America Omega-3 Fatty Acid Drugs Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Omega-3 Fatty Acid Drugs Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Omega-3 Fatty Acid Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Omega-3 Fatty Acid Drugs Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Omega-3 Fatty Acid Drugs Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Omega-3 Fatty Acid Drugs Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Omega-3 Fatty Acid Drugs Revenue by Country (US$ Million), 2027–2032
Table 50. Global Omega-3 Fatty Acid Drugs Sales (K Units) by Type (2021–2026)
Table 51. Global Omega-3 Fatty Acid Drugs Sales (K Units) by Type (2027–2032)
Table 52. Global Omega-3 Fatty Acid Drugs Sales Market Share by Type (2021–2026)
Table 53. Global Omega-3 Fatty Acid Drugs Sales Market Share by Type (2027–2032)
Table 54. Global Omega-3 Fatty Acid Drugs Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Omega-3 Fatty Acid Drugs Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Omega-3 Fatty Acid Drugs Revenue Market Share by Type (2021–2026)
Table 57. Global Omega-3 Fatty Acid Drugs Revenue Market Share by Type (2027–2032)
Table 58. Global Omega-3 Fatty Acid Drugs Price (US$/Unit) by Type (2021–2026)
Table 59. Global Omega-3 Fatty Acid Drugs Price (US$/Unit) by Type (2027–2032)
Table 60. Global Omega-3 Fatty Acid Drugs Sales (K Units) by Application (2021–2026)
Table 61. Global Omega-3 Fatty Acid Drugs Sales (K Units) by Application (2027–2032)
Table 62. Global Omega-3 Fatty Acid Drugs Sales Market Share by Application (2021–2026)
Table 63. Global Omega-3 Fatty Acid Drugs Sales Market Share by Application (2027–2032)
Table 64. Global Omega-3 Fatty Acid Drugs Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Omega-3 Fatty Acid Drugs Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Omega-3 Fatty Acid Drugs Revenue Market Share by Application (2021–2026)
Table 67. Global Omega-3 Fatty Acid Drugs Revenue Market Share by Application (2027–2032)
Table 68. Global Omega-3 Fatty Acid Drugs Price (US$/Unit) by Application (2021–2026)
Table 69. Global Omega-3 Fatty Acid Drugs Price (US$/Unit) by Application (2027–2032)
Table 70. Woodward Pharma Company Information
Table 71. Woodward Pharma Description and Business Overview
Table 72. Woodward Pharma Omega-3 Fatty Acid Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Woodward Pharma Omega-3 Fatty Acid Drugs Product
Table 74. Woodward Pharma Recent Developments/Updates
Table 75. Amarin Pharmaceuticals Company Information
Table 76. Amarin Pharmaceuticals Description and Business Overview
Table 77. Amarin Pharmaceuticals Omega-3 Fatty Acid Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Amarin Pharmaceuticals Omega-3 Fatty Acid Drugs Product
Table 79. Amarin Pharmaceuticals Recent Developments/Updates
Table 80. Apotex Company Information
Table 81. Apotex Description and Business Overview
Table 82. Apotex Omega-3 Fatty Acid Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Apotex Omega-3 Fatty Acid Drugs Product
Table 84. Apotex Recent Developments/Updates
Table 85. Hikma Company Information
Table 86. Hikma Description and Business Overview
Table 87. Hikma Omega-3 Fatty Acid Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Hikma Omega-3 Fatty Acid Drugs Product
Table 89. Hikma Recent Developments/Updates
Table 90. Dr. Reddy's Laboratories Company Information
Table 91. Dr. Reddy's Laboratories Description and Business Overview
Table 92. Dr. Reddy's Laboratories Omega-3 Fatty Acid Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Dr. Reddy's Laboratories Omega-3 Fatty Acid Drugs Product
Table 94. Dr. Reddy's Laboratories Recent Developments/Updates
Table 95. Teva Company Information
Table 96. Teva Description and Business Overview
Table 97. Teva Omega-3 Fatty Acid Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Teva Omega-3 Fatty Acid Drugs Product
Table 99. Teva Recent Developments/Updates
Table 100. Ascent Pharmaceuticals Company Information
Table 101. Ascent Pharmaceuticals Description and Business Overview
Table 102. Ascent Pharmaceuticals Omega-3 Fatty Acid Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Ascent Pharmaceuticals Omega-3 Fatty Acid Drugs Product
Table 104. Ascent Pharmaceuticals Recent Developments/Updates
Table 105. Zydus Company Information
Table 106. Zydus Description and Business Overview
Table 107. Zydus Omega-3 Fatty Acid Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Zydus Omega-3 Fatty Acid Drugs Product
Table 109. Zydus Recent Developments/Updates
Table 110. Strides Pharma Company Information
Table 111. Strides Pharma Description and Business Overview
Table 112. Strides Pharma Omega-3 Fatty Acid Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Strides Pharma Omega-3 Fatty Acid Drugs Product
Table 114. Strides Pharma Recent Developments/Updates
Table 115. PuraCap Pharmaceuticals Company Information
Table 116. PuraCap Pharmaceuticals Description and Business Overview
Table 117. PuraCap Pharmaceuticals Omega-3 Fatty Acid Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. PuraCap Pharmaceuticals Omega-3 Fatty Acid Drugs Product
Table 119. PuraCap Pharmaceuticals Recent Developments/Updates
Table 120. Sun Pharma Company Information
Table 121. Sun Pharma Description and Business Overview
Table 122. Sun Pharma Omega-3 Fatty Acid Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Sun Pharma Omega-3 Fatty Acid Drugs Product
Table 124. Sun Pharma Recent Developments/Updates
Table 125. Mankind Pharma Company Information
Table 126. Mankind Pharma Description and Business Overview
Table 127. Mankind Pharma Omega-3 Fatty Acid Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. Mankind Pharma Omega-3 Fatty Acid Drugs Product
Table 129. Mankind Pharma Recent Developments/Updates
Table 130. Amneal Pharmaceuticals Company Information
Table 131. Amneal Pharmaceuticals Description and Business Overview
Table 132. Amneal Pharmaceuticals Omega-3 Fatty Acid Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 133. Amneal Pharmaceuticals Omega-3 Fatty Acid Drugs Product
Table 134. Amneal Pharmaceuticals Recent Developments/Updates
Table 135. GLW Pharma Company Information
Table 136. GLW Pharma Description and Business Overview
Table 137. GLW Pharma Omega-3 Fatty Acid Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 138. GLW Pharma Omega-3 Fatty Acid Drugs Product
Table 139. GLW Pharma Recent Developments/Updates
Table 140. Sichuan Gowell Pharmaceutical Company Information
Table 141. Sichuan Gowell Pharmaceutical Description and Business Overview
Table 142. Sichuan Gowell Pharmaceutical Omega-3 Fatty Acid Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 143. Sichuan Gowell Pharmaceutical Omega-3 Fatty Acid Drugs Product
Table 144. Sichuan Gowell Pharmaceutical Recent Developments/Updates
Table 145. Qilu Pharmaceutical Company Information
Table 146. Qilu Pharmaceutical Description and Business Overview
Table 147. Qilu Pharmaceutical Omega-3 Fatty Acid Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 148. Qilu Pharmaceutical Omega-3 Fatty Acid Drugs Product
Table 149. Qilu Pharmaceutical Recent Developments/Updates
Table 150. Chengdu Suncadia Medicine Company Information
Table 151. Chengdu Suncadia Medicine Description and Business Overview
Table 152. Chengdu Suncadia Medicine Omega-3 Fatty Acid Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 153. Chengdu Suncadia Medicine Omega-3 Fatty Acid Drugs Product
Table 154. Chengdu Suncadia Medicine Recent Developments/Updates
Table 155. Jiangsu Wangao Pharmaceutical Company Information
Table 156. Jiangsu Wangao Pharmaceutical Description and Business Overview
Table 157. Jiangsu Wangao Pharmaceutical Omega-3 Fatty Acid Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 158. Jiangsu Wangao Pharmaceutical Omega-3 Fatty Acid Drugs Product
Table 159. Jiangsu Wangao Pharmaceutical Recent Developments/Updates
Table 160. Humanwell Puracap Pharmaceuticals Company Information
Table 161. Humanwell Puracap Pharmaceuticals Description and Business Overview
Table 162. Humanwell Puracap Pharmaceuticals Omega-3 Fatty Acid Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 163. Humanwell Puracap Pharmaceuticals Omega-3 Fatty Acid Drugs Product
Table 164. Humanwell Puracap Pharmaceuticals Recent Developments/Updates
Table 165. Key Raw Materials Lists
Table 166. Raw Materials Key Suppliers Lists
Table 167. Omega-3 Fatty Acid Drugs Distributors List
Table 168. Omega-3 Fatty Acid Drugs Customers List
Table 169. Omega-3 Fatty Acid Drugs Market Trends
Table 170. Omega-3 Fatty Acid Drugs Market Drivers
Table 171. Omega-3 Fatty Acid Drugs Market Challenges
Table 172. Omega-3 Fatty Acid Drugs Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
Table 176. Authors List of This Report
List of Figures
Figure 1. Product Picture of Omega-3 Fatty Acid Drugs
Figure 2. Global Omega-3 Fatty Acid Drugs Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Omega-3 Fatty Acid Drugs Market Share by Type: 2025 & 2032
Figure 4. EPA Product Picture
Figure 5. EPA and DHA Product Picture
Figure 6. Global Omega-3 Fatty Acid Drugs Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Omega-3 Fatty Acid Drugs Market Share by Application: 2025 & 2032
Figure 8. Hospital Pharmacy
Figure 9. Retail Pharmacy
Figure 10. Online Pharmacy
Figure 11. Global Omega-3 Fatty Acid Drugs Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global Omega-3 Fatty Acid Drugs Market Size (US$ Million), 2021–2032
Figure 13. Global Omega-3 Fatty Acid Drugs Sales (K Units), 2021–2032
Figure 14. Global Omega-3 Fatty Acid Drugs Average Price (US$/Unit), 2021–2032
Figure 15. Omega-3 Fatty Acid Drugs Report Years Considered
Figure 16. Omega-3 Fatty Acid Drugs Sales Share by Manufacturers in 2025
Figure 17. Global Omega-3 Fatty Acid Drugs Revenue Share by Manufacturers in 2025
Figure 18. Top 5 and Top 10 Global Omega-3 Fatty Acid Drugs Players: Market Share by Revenue in Omega-3 Fatty Acid Drugs in 2025
Figure 19. Omega-3 Fatty Acid Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 20. Global Omega-3 Fatty Acid Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 21. North America Omega-3 Fatty Acid Drugs Sales Market Share by Country (2021–2032)
Figure 22. North America Omega-3 Fatty Acid Drugs Revenue Market Share by Country (2021–2032)
Figure 23. United States Omega-3 Fatty Acid Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Canada Omega-3 Fatty Acid Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Europe Omega-3 Fatty Acid Drugs Sales Market Share by Country (2021–2032)
Figure 26. Europe Omega-3 Fatty Acid Drugs Revenue Market Share by Country (2021–2032)
Figure 27. Germany Omega-3 Fatty Acid Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. France Omega-3 Fatty Acid Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. U.K. Omega-3 Fatty Acid Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Italy Omega-3 Fatty Acid Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Russia Omega-3 Fatty Acid Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Asia Pacific Omega-3 Fatty Acid Drugs Sales Market Share by Region (2021–2032)
Figure 33. Asia Pacific Omega-3 Fatty Acid Drugs Revenue Market Share by Region (2021–2032)
Figure 34. China Omega-3 Fatty Acid Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Japan Omega-3 Fatty Acid Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. South Korea Omega-3 Fatty Acid Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. India Omega-3 Fatty Acid Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Australia Omega-3 Fatty Acid Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. China Taiwan Omega-3 Fatty Acid Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Southeast Asia Omega-3 Fatty Acid Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Latin America Omega-3 Fatty Acid Drugs Sales Market Share by Country (2021–2032)
Figure 42. Latin America Omega-3 Fatty Acid Drugs Revenue Market Share by Country (2021–2032)
Figure 43. Mexico Omega-3 Fatty Acid Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Brazil Omega-3 Fatty Acid Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Argentina Omega-3 Fatty Acid Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Colombia Omega-3 Fatty Acid Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Middle East and Africa Omega-3 Fatty Acid Drugs Sales Market Share by Country (2021–2032)
Figure 48. Middle East and Africa Omega-3 Fatty Acid Drugs Revenue Market Share by Country (2021–2032)
Figure 49. Turkey Omega-3 Fatty Acid Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Saudi Arabia Omega-3 Fatty Acid Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. UAE Omega-3 Fatty Acid Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Global Sales Market Share of Omega-3 Fatty Acid Drugs by Type (2021–2032)
Figure 53. Global Revenue Market Share of Omega-3 Fatty Acid Drugs by Type (2021–2032)
Figure 54. Global Omega-3 Fatty Acid Drugs Price (US$/Unit) by Type (2021–2032)
Figure 55. Global Sales Market Share of Omega-3 Fatty Acid Drugs by Application (2021–2032)
Figure 56. Global Revenue Market Share of Omega-3 Fatty Acid Drugs by Application (2021–2032)
Figure 57. Global Omega-3 Fatty Acid Drugs Price (US$/Unit) by Application (2021–2032)
Figure 58. Omega-3 Fatty Acid Drugs Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Trichosanthes Kirilowii Extract Market Research Report 2026
Feb 24, 26
Global Glass Lined Containers Market Research Report 2026
Feb 24, 26
Global Open End Wrenches Market Research Report 2026
Feb 24, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232